- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02047383
Hospital Stay and Respiratory Infection
November 2, 2016 updated by: Marie Carmen Valenza, Universidad de Granada
Repercussion of Hospital Stay in Patients With Respiratory Infection
The acute respiratory infection is the fourth most common cause of hospital stay between elderly people.
The purpose of this study is to evaluate the repercussion of hospital stay in hospitalized patients with a respiratory infection.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Acute respiratory infection is a serious infection that prevents normal breathing function.
It refers to any of a number of infectious diseases involving the respiratory tract.
Health conditions that increase the risk of a respiratory infection include: another lung condition, a heart condition, a kidney or liver condition and a lowered immune system.
The hospital stay of this patients is approximately 7-10 days and it is important to study the effects of this stay in the physical and psycho-emotional characteristics of patients.
Study Type
Observational
Enrollment (Actual)
116
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Granada, Spain, 18071
- Faculty of health Sciences. University of Granada
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Hospitalized patients with an acute respiratory infection
Description
Inclusion Criteria:
- Diagnosis of respiratory infection
- Age: more than 50 year.
- Signed written consent.
Exclusion Criteria:
- Heart disease and concomitant neurological condition.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
respiratory infection
Hospitalized patients with a respiratory infection
|
An assessment of the patients included in the study will be conducted
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Strength in upper and lower limbs
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 8 days
|
The quadriceps and the hand-grip strength is assessed using a dynamometer with a standard protocol allowing three attempts on each side.
During each measurement, patients were sitting with their shoulder adducted and elbow flexed to 90°.
The maximum value achieved was used in the analyses.
This is important in order to quantify the increase of strength Kg/cm2 The test 2-minute step in place is also going to be used for this purpose, counting the times the patients go up the right knees in two minutes.
|
Participants will be followed for the duration of hospital stay, an expected average of 8 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of life
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 8 days
|
The quality of life associated with health is going to be measure with t the EuroQol-5 questionnaire.
|
Participants will be followed for the duration of hospital stay, an expected average of 8 days
|
Lung function
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 8 days
|
Lung function is going to be evaluated using a spirometer.
|
Participants will be followed for the duration of hospital stay, an expected average of 8 days
|
Activity monitoring
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 8 days
|
The accelerometer Armband is going to be used for activity monitoring.
It measures the intensity of the activity during 12 hours.
|
Participants will be followed for the duration of hospital stay, an expected average of 8 days
|
Quality of sleep
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 8 days
|
Changes in quality of sleep.
For this purpose, the participants are going to complete the Pittsburgh Quality of Sleep Index.
This is a self-rating questionnaire with seven subscores that result in a global score between 0 and 21.
|
Participants will be followed for the duration of hospital stay, an expected average of 8 days
|
Mood
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 8 days
|
Mood in these patients will be measured by the Hospital Anxiety and Depression Scale.
|
Participants will be followed for the duration of hospital stay, an expected average of 8 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2014
Primary Completion (Actual)
May 1, 2014
Study Completion (Actual)
August 1, 2014
Study Registration Dates
First Submitted
January 22, 2014
First Submitted That Met QC Criteria
January 26, 2014
First Posted (Estimate)
January 28, 2014
Study Record Updates
Last Update Posted (Estimate)
November 3, 2016
Last Update Submitted That Met QC Criteria
November 2, 2016
Last Verified
November 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DF0047UG
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Infection
-
SciensanoJessa Hospital; Universitair Ziekenhuis Brussel; AZ Sint-Jan AV; Centre Hospitalier... and other collaboratorsCompletedInfluenza Viral Infections | Respiratory Viral Infection | Severe Acute Respiratory Infection
-
Vedic Lifesciences Pvt. Ltd.Completed
-
University of MontanaNational Institute of Environmental Health Sciences (NIEHS)CompletedLower Tract Respiratory InfectionUnited States
-
European Clinical Research Alliance for Infectious...UMC Utrecht; University of OxfordNot yet recruitingAcute Respiratory Infection | Acute Respiratory Tract Infection
-
NPO PetrovaxCompletedAcute Respiratory InfectionRussian Federation
-
University of Wisconsin, MadisonNational Center for Complementary and Integrative Health (NCCIH)CompletedAcute Respiratory InfectionUnited States
-
Materia Medica HoldingCompletedViral Respiratory Infection
-
Reckitt Benckiser LLCCompletedAcute Respiratory InfectionUnited States
-
Seattle Children's HospitalChildren's Hospital of Philadelphia; University of California, Los Angeles; University... and other collaboratorsUnknownRespiratory Disease | Acute Respiratory Infection | Upper Respiratory Infection | Respiratory InfectionUnited States
-
Makerere UniversityMRC/UVRI and LSHTM Uganda Research Unit; Makerere University Lung Institute; Directorate... and other collaboratorsRecruitingAcute Respiratory InfectionUganda
Clinical Trials on Respiratory infection
-
Rennes University HospitalCompletedHeart; Surgery, Heart, Functional Disturbance as ResultFrance
-
Malaria ConsortiumUNICEF; Ministry of Health, Ethiopia; La Caixa FoundationTerminatedPneumonia ChildhoodEthiopia
-
Szeged UniversityRecruitingLong COVID | Respiratory Function TestsHungary
-
Hospices Civils de LyonCompletedInfection ViralFrance
-
University Hospital, RouenRecruitingCorona Virus InfectionFrance
-
Leiden University Medical CenterCompletedSchistosomiasis | Schistosoma MansoniNetherlands
-
Nantes University HospitalCompleted
-
Daping Hospital and the Research Institute of Surgery...Children's Hospital of Chongqing Medical UniversityCompletedBacterial Infections | Viral Infection | Lactate Blood IncreaseChina
-
Peking University People's HospitalUnknownArthropathy of Knee | Arthropathy of Hip
-
University of WashingtonTerminated